Rallis India Limited has fixed Thursday, June 4, 2026, as the record date to determine the entitlement of members for the final dividend for the financial year ended March 31, 2026. The Board of Directors had previously recommended a dividend of ₹3.00 per equity share of Re. 1.00 each (300%) at its meeting held on April 27, 2026. The dividend is subject to approval by members at the 78th Annual General Meeting.

Annual General Meeting Details

The 78th Annual General Meeting of the company will be held on Tuesday, June 23, 2026, at 3.00 p.m. (IST) through Video Conference (VC) or Other Audio Visual Means (OAVM). The notice of the AGM along with the Integrated Annual Report 2025-26 will be sent electronically to members. Members whose email addresses are not registered are requested to send their details to the company by June 16, 2026, to receive the notice and e-voting credentials.

Key Dates and Entitlement

The schedule for the dividend payout and the AGM is summarised below:

Tax Deduction and Compliance

Dividend income is taxable in the hands of shareholders, and the company is required to deduct tax at source (TDS) under the provisions of the Income Tax Act, 1961. To ensure compliance, shareholders must update their residential status, PAN, and category details with their depositories or the Registrar and Transfer Agent, MUFG Intime India Private Limited, before the record date.

Shareholders wishing to avail tax exemption must submit Form 15G/15H or other relevant documents by June 2, 2026. Resident shareholders with valid PAN are subject to a 10% TDS rate, while those without PAN or with inoperative PAN (Aadhaar not linked) face a 20% deduction. Non-resident shareholders must submit specific documents, including a Tax Residency Certificate, to claim benefits under Double Tax Avoidance Agreements.

Payment Mode Update

Pursuant to SEBI directives effective from November 19, 2025, payment of dividends will be processed only via electronic mode. Payments through dividend warrants or cheques have been discontinued. Shareholders holding shares in physical form must ensure their folios are KYC compliant and submit bank account details to the registrar by June 2, 2026. Those holding shares in demat form must update their Electronic Bank Mandate with their depository participants.

Rallis India reported its Q4 and full-year FY26 financial results during an Analyst/Investors Earnings Conference Call held on April 28, 2026. The call was addressed by Dr. Gyanendra Shukla, Managing Director and CEO, and Mr. Bhaskar Swaminathan, Chief Financial Officer. The company delivered a reasonable performance despite a short Rabi season, geopolitical unrest, and ongoing global supply chain disruptions.

Q4FY26 Financial Performance

For the quarter ended March 31, 2026, Rallis India posted revenue of ₹456 cr, compared to ₹430 cr in Q4FY25, representing overall growth of approximately 6%. Volume growth stood at approximately 5% with pricing contributing approximately 1%. The following table summarises key financial metrics for Q4FY26:

Exceptional items for the quarter included a profit on sale of property of Aurangabad Land of ₹3 cr.

Segment-Wise Q4FY26 Performance

The Crop Care segment grew 5% to ₹425 cr in Q4FY26 from ₹405 cr in Q4FY25, driven by volume expansion, new product promotion, and increased digital engagement. Within the domestic B2C business, revenue grew 15% to ₹255 cr from ₹222 cr in Q4FY25, primarily led by volume growth of 14% in insecticides. The Soil & Plant Health (SPH) category registered robust growth of 27% to ₹47 cr from ₹37 cr, with volume growth of 29% driven by Micronutrients and Biofertilizers.

The Seeds business delivered revenue growth of 23% to ₹31 cr from ₹25 cr in Q4FY25, supported by 8% volume growth and 15% price growth, mainly driven by cotton and millets. On the B2B side, exports de-grew 33% to ₹77 cr from ₹114 cr due to volume and revenue decline in Metribuzin and Pendimethalin. However, the CSM (Contract and Specialty Manufacturing) business recorded strong growth of 59% to ₹66 cr from ₹41 cr, driven by both volume and price growth. Total B2B revenue stood at ₹170 cr versus ₹182 cr, a decline of 7% primarily due to volumes.

Full-Year FY26 Performance

For the full financial year FY26, Rallis India's topline revenue stood at ₹2897 cr, reflecting 9% year-on-year growth. Crop Care revenue stood at ₹2416 crore, reflecting 8% growth year-on-year, driven by volume expansion despite price softness. Seeds revenue increased to ₹481 crore, delivering 15% growth year-on-year, supported by cotton and maize along with improved contribution from in-licensed products.

The B2C business recorded growth of 5%, delivering ₹1657 cr of revenue, primarily contributed by 9% volume growth. The B2B business recorded growth of 14%, delivering ₹759 cr of revenue, supported by both volume and price growth and expansion of the customer base. On a yearly basis, the herbicide business grew by 15%, fungicide by 5%, while insecticide declined by 3%.

The company maintained a healthy cash and liquid balance of ₹541 cr as of March 31, 2026. Inventory levels remained slightly elevated compared to the same quarter of the previous year, while collection cycles remained smooth.

New Products, Initiatives and Operational Highlights

During the quarter, Rallis India launched several new products and digital initiatives:

• ALSTOR: A dual action granular insecticide
• FIPLAM: A broad-spectrum formulation designed to manage both sucking and chewing pests
• Spiro: A three-way patented herbicide for Paddy (registration obtained)
• Seeds: Two new products launched across core crops
• Idea2Impact platform: An open innovation ecosystem to source, validate, and commercialise agri-innovations
• Saksham (GIS platform): Enables scientific identification of high-potential villages for targeted market expansion
• Sampark Plus: Captures farmer-level demand signals to generate actionable insights and improve sales conversion

The company also reported record production levels as a result of improved manufacturing efficiency and operational excellence. Overall annual capacity utilisation improved in FY26 compared to FY25.

Industry Landscape and Key Risk Factors

Management highlighted that the Indian agrochemical sector is transitioning from a buyers' to a sellers' market due to war-induced supply constraints and rising prices. Key agrochemicals, particularly Glyphosate (up approximately 25%), are facing rising costs from inflation-driven pass-throughs and China supply disruptions. Raw material cost increases of 15% to 25% have been observed across the portfolio.

On the agricultural outlook, the IMD's 2026 monsoon forecast at 92% of Longest Period Average (LPA) signals below-normal rains, with rising El Niño odds driving early deficits in North, Central, and Western India. As of end of March 2026, summer sowing was progressing at a slower pace, down 4.7% year-on-year, primarily driven by declines in Rice (-7.1%), Cereals (-3.8%), and Oilseeds (-6.1%). Unseasonal rains and hailstorms damaged Rabi crops across 2.49 lakh hectares, with wheat suffering the maximum impact. The global crop protection market is estimated at approximately USD 70–75 billion in 2026 and is projected to grow at a CAGR of around 5.0–5.5%.

Management noted that the company is focused on securing Kharif supply, passing on cost increases where possible, maintaining calibrated inventory build-up, and driving portfolio rationalisation across both Crop Care and Seeds segments. The Seeds business is focusing on five strategic crops: Cotton, Maize, Millet, Mustard, and Rice.